Potential risk: I must admit for an OTC Pink Sheet company such as BIEI to have this technology is a far stretch for anyone to comprehend. One would think that NYSE and NASDAQ level companies would be working on such technologies and would be the ones working with companies at the level of Lockheed Martin. I read and understood your post, but for me seeing will be believing if this potential virus treatment is in fact true. BIEI will need to confirm the potential with an official PR. Time will tell if this is true.
Further to your post stervc, I have been looking for information on Lockheed Martin and its efforts and challenges related to the coronavirus. Below is a summary of what I have been able to find and piece together in order to possibly connect the dots. My thoughts below are all IMO and I have not verified any of them. I could be wrong, so please take my thoughts for what they are worth with a grain of salt.
1. Protecting Operations and Revenues: Presented below are a few screenshots of news articles with how Lockheed Martin is handling the coronavirus challenges to its operations. I think a potential virus treatment by BIEI would help Lockheed Martin potentially protect its employees and ensure its plane building operations are not disrupted to ensure revenues from selling the expensive air force planes and other defence systems will not be disrupted.
2. Good Corporate Citizen: Presented below are a few screenshots of news articles with how Lockheed Martin is being a good corporate citizen to support suppliers in the supply chain, hire employees and donate its facilities in order to help out in this pandemic situation. I think a potential virus treatment by BIEI might catch Lockheed Martin’s interest to help support and/or secure funding for continuing the research to evolve its role as a good corporate citizen to help out American during this difficult time.
3. Providing a Solution/Technology to the U.S. Armed Forces and other countries: There may be a potential value to Lockheed Martin in the Patents and Covid-19 Treatment Provisional Patent Application Filed by BIEI to help Lockheed Martin provide the U.S. Armed Forces, its main client, and allies around the world with a potential medical solution to protect their personnel and civilians. Such a virus medical solution may help expand Lockheed Martin’s revenue portfolio and help support its armed forces clients with different products and technologies to combat the pandemic for their countries. Time will tell if this in fact will happen.
As stated above, seeing will be believing for me if BIEI’s potential virus treatment is in fact true and catches the attention of companies at the level of Lockheed Martin which BIEI will need to confirm with an official PR. Time will tell. Once again, all of the above is IMO and my thoughts have not been verified and could be wrong
If BIEI's coronavirus technology in fact proves to be true and verifiable, the interim BIEI pps fluctuations in the double zeros will be prove to be inconsequential and especially given BIEI’s pps recent climb out of the triple zeros. IMO.